Research Row: Impacting Downstream Capricor Therapeutics (Cap-1002) Edgewise Therapeutics (EDG-5506) FibroGen (Pamrevlumab) Antisense Therapeutics (ATL1102) Cumberland Pharmaceuticals (Ifetroban) 2023 PPMD Annual Conference,Conferences & Meetings 1 year ago You may also like 1:18:24 Panel Discussion: Facilitating Independence — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 31:10 The Landscape of Cardiac Care: Emerging Therapies on the Horizon — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 54:15 Emergency Care in Duchenne — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 8:36 Here Is What I Hear — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 39:20 The Future of Genetic Therapies — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 1:30:40 Gene Therapy Approaches to Replace or Restore Dystrophin — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 25:56 Gene Therapy Era: What We Know — PPMD 2022 Annual Conference 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings 32:14 Duchenne Siblings Panel: What We Want You To Know — PPMD 2022 Annual Meeting 2 years ago 2022 PPMD Annual Conference,Conferences & Meetings «1…7891011…25»Page 9 of 25
by: Parent Project Muscular Dystrophy
